Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Hyloris Pharmaceuticals SA HYL.BR
$12.30
-$0.2 (-1.60%)
На 18:03, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
347204960.00000000
-
week52high
16.16
-
week52low
11.20
-
Revenue
2951000
-
P/E TTM
-28
-
Beta
0.71045000
-
EPS
-0.32000000
-
Last Dividend
0.00000000
-
Next Earnings Date
15 мар 2023 г. в 19:00
Описание компании
Hyloris Pharmaceuticals SA engages in the develop, manufacture, and deliver pharmaceutical products to address unmet medical needs in cardiovascular health, oncology, women's health, and other major therapeutic areas. The company offers cardiovascular products for atrial fibrillation, acute coronary syndrome, advanced heart failure, congestive heart failure, acute coronary syndrome, and coronary heart disease. It also provides other products, such as post operation pain, dental indications, severe and recurring vulvovaginal candidiasis, acute myeloid leukemia and small cell lung cancer, IC/PBS, attention deficit hyperactivity disorder, and viral infection. Hyloris Pharmaceuticals SA was incorporated in 2012 and is headquartered in Liège, Belgium.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии